Loading…
Prescription Drug Affordability Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
74pct
27d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2012 · fourth_quarter · Pharmacy
Bills with similar content found using semantic analysis.
Sources: Congress.gov
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Pharmacy
S. 27, Preserve Access to Affordable Generics Act S. 31, Prescription Drug and Health Improvement Act of 2011 S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147, Prescription Drug Affordability Act H.R. 741, To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1971, Pharmacy Competition and consumer Choice Act of 2011 H.R. 2128, STEAM (Stripping the E-Prescribe Arbitrary Mandates) Act of 2011 S. 1058, Pharmacy Competition and Consumer Act of 2011 S. 1356, Affordable Medicines Utilization Act of 2011 S. 1584, Drug Safety and Accountability Act of 2011 H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 S. 2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies S. 3187, FDA Safety and Innovation Act
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
2012 · fourth_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/PL 112-144/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/PL 112-144) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/PL 112-144) Counterfeit Drugs (S. 1886/H.R. 3668/PL 112-144) ***, no specific bills, supply chain integrity, prescription drug abuse
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Medicare/Medicaid
General Medicare Protection, Prescription Drug Reimportation: H.R. 147 and S. 319; Medicare Prescription Drug Improvement: H.R. 3613; Waste and Fraud in Medicare: H.R. 3735, and H.Res. 666; Repeal of Sustainable Growth Rate: H.R. 5707.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/S.3187/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/S. 3187) Cargo/Product Theft (S. 1002/H.R. 4223) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/S. 3187) Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) ***, no specific bills, supply chain integrity, prescription drug abuse
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimlars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Pharmacy
S. 27, Preserve Access to Affordable Generics Act S. 31, Prescription Drug and Health Improvement Act of 2011 S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147, Prescription Drug Affordability Act H.R. 741, To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1971, Pharmacy Competition and consumer Choice Act of 2011 H.R. 2128, STEAM (Stripping the E-Prescribe Arbitrary Mandates) Act of 2011 S. 1058, Pharmacy Competition and Consumer Act of 2011 S. 1356, Affordable Medicines Utilization Act of 2011 S. 1584, Drug Safety and Accountability Act of 2011 H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 S. 2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies S. 3187, FDA Safety and Innovation Act
Client expense: $440,000 · Firm income: Not reported
2012 · third_quarter · Medicare/Medicaid
General Medicare Protection, Prescription Drug Reimportation: H.R. 147 and S. 319; Medicare Prescription Drug Improvement: H.R. 3613; Waste and Fraud in Medicare: H.R. 3735 and H.Res. 666; Repeal of Sustainable Growth Rate: H.R. 5707.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Pharmacy
S. 27, Preserve Access to Affordable Generics Act S. 31, Prescription Drug and Health Improvement Act of 2011 S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147, Prescription Drug Affordability Act H.R. 741, To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1971, Pharmacy Competition and consumer Choice Act of 2011 H.R. 2128, STEAM (Stripping the E-Prescribe Arbitrary Mandates) Act of 2011 S. 1058, Pharmacy Competition and Consumer Act of 2011 S. 1356, Affordable Medicines Utilization Act of 2011 S. 1584, Drug Safety and Accountability Act of 2011 H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 S. 2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies S. 3187, FDA Safety and Innovation Act
Client expense: $560,000 · Firm income: Not reported
2012 · second_quarter · Medicare/Medicaid
General Medicare Protection Prescription Reimportation HR 147 and S 319; Medicare Prescription Drug Improvement HR 3613; Waste and Fraud in Medicare HR 3735 and H.Res 666; Repeal of Sustainable Growth Rate: HR 5707
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimlars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/S.3187/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/S. 3187) Cargo/Product Theft (S. 1002/H.R. 4223) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/S. 3187) Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) Internet Pharmacey (S. 2002/H.R. 4095) ***, no specific bills: supply chain integrity, prescription drug abuse, internet pharmacy regulation
Client expense: Not reported · Firm income: $60,000
2012 · second_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R. 5651 & S. 2516 & S.3187 to drug shortages
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Pharmacy
Importation of Prescription Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Presecription Drug Monitoring Programs (S. 2254/H.R. 4292/S. 3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S.1002/H.R. 4223); Import Safety(S.1584); Counterfeit Drugs(S.1886/H.R. 3668/S.3187); Internet Pharmacy(S.2002/H.R. 4095)
Client expense: $323,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245/H.R. 3839) Rx Pedigree (H.R. 3026) Cargo/Product Theft (S. 1002/H.R. 4223) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292) Counterfeit Drugs (S. 1886/H.R. 3668) Internet Pharmacey (S. 2002/H.R. 4095) ***, no specific bills, federal pedigree, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Health Issues
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act ***, no specific bill(s), prescription drug importation, import safety, Prescription Drug User Fee Act and associated policies
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA and associated policies
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Pharmacy
S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 S.1356, Affordable Medicines Utilization Act of 2011 S.1584, Drug Safety and Accountability Act of 2011 H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011 S.2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies
Client expense: $560,000 · Firm income: Not reported
2012 · first_quarter · Pharmacy
Importation of Presceiption Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/draft PDUFA legislation); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245/H.R. 3839/draft PDUFA legislation); Cargo/Product Theft (S. 1002/H.R. 4223); Import Safety (S. 1584); Counterfeit Drugs (S. 1886/H.R. 3668); Internet Pharmacy (S. 2002/H.R. 4095)
Client expense: $282,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Medicare/Medicaid
General Medicare Protection, Prescription Drug Reimportation: H.R. 147 and S. 319; Medicare Prescription Drug Improvement: H.R. 3613; Waste and Fraud in Medicare: H.R. 3735
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011 S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245) Rx Pedigree (H.R. 3026) Cargo/Product Theft (S. 1002) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) **no specific bills, federal pedigree, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012, drug importation ***, no specific bill(s), prescription drug importation, import safety, Prescription Drug User Fee Act and associated policies
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012, drug importation ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA and associated policies
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 S.1356, Affordable Medicines Utilization Act of 2011 S.1584, Drug Safety and Accountability Act of 2011 H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011 S.2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies
Client expense: $380,000 · Firm income: Not reported
2011 · fourth_quarter · Health Issues
Discussions related to drug importation and IPAB (S.319, S. 688, H.R. 147, H.R.2112/Admt769) Discussions related to budget and debt ceiling (S.365) Discussions regarding drug shortages (H.R. 2245, S. 296)
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Pharmacy
Importation of Preseciption Drugs (S.319, H.R. 147); Rx Pedigree (H.R. 3026); NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245); Cargo/Product Theft (S. 1002); Import Safety (S. 1584)
Client expense: $280,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · fourth_quarter · Medicare/Medicaid
General Medicare Protection, Prescription Drug Reimportation: H.R. 147 and S. 319, Medicare Prescription Drug Improvement: H.R. 3613
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Medicare/Medicaid
General Medicare Protection, Prescription Drug Reimportation: H.R. 147 and S. 319; Medicare Prescription Improvement: H.R. 3613
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Pharmacy
**see addendum page ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act ***, no specific bill(s), prescription drug importation, import safety, Prescription Drug User Fee Act and associated policies
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Pharmacy
**see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA and associated policies
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Pharmacy
**see addendum page Importation of prescription drugs (S.319/H.R. 147) Methamphetamine/Pseudoephedrine Regulation NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245) Rx Pedigree (H.R. 3206) Cargo/Product Theft (S. 1002) Import Safety (S. 1584) **no specific bills, federal pedigree, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Pharmacy
S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 S.1356, Affordable Medicines Utilization Act of 2011 S.1584, Drug Safety and Accountability Act of 2011 H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011
Client expense: $440,000 · Firm income: Not reported
2011 · third_quarter · Medicare/Medicaid
In support of General Medicare Protection, Prescription Drug Reimportation: H.R. 147, S. 319
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Pharmacy
Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Pharmacy
Importationof prescription drugs (S.319, H.R. 147), Rx Pedigree (H.R. 3026), Methamphetamine/Pseudoephedrine Regulation, NASPER Reauthorization (H.R. 866), Pill Mill Crackdown Act (H.R. 1065), Drug Abuse (S.507), Drug Shortages (S. 296/H.R. 2245), Cargo/Product Theft (S. 1002), Import Safety (S. 1584)
Client expense: $264,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · third_quarter · Medicare/Medicaid
General Medicare Protection, Prescription Drug Reimportation: H.R. 147, S. 319
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), SENATE